Parkinson’s Research to Gain in Van Andel Institute’s Expansion
The Van Andel Research Institute (VARI) has announced the expansion of its neurodegenerative disease research program, with Dr. Gerhard Coetzee…
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
The Van Andel Research Institute (VARI) has announced the expansion of its neurodegenerative disease research program, with Dr. Gerhard Coetzee…
Lund University researchers have shown that cerebrospinal fluid (CSF) biomarkers of angiogenesis are raised in Parkinson’s disease (PD) patients and…
Researchers from the University of Kentucky presented the results of their research on a potential novel therapy for the treatment of…
A new case control study evaluated the association between caffeine consumption and risk of developing Parkinson’s disease (PD) in patients with high…
University of Dundeen scientists have uncovered the molecular mechanisms and targets under the effect of a specific gene mutation involved in…
Researchers at King’s College London have identified a gene, HIFalpha, that plays a role in the regulation of nerve signals…
Researchers at the Georgetown University Medical Center reported nilotinib (Tasigna® by Novartis), a treatment for chronic myelogenous leukemia (CML), successfully…
Researchers at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, have linked lack of signaling by the immune…
Get regular updates to your inbox.